13FProtagonist Therapeutics Inc (PTGX)
2 tracked managers currently hold PTGX on their latest filing. Change is versus that manager’s previous filing. Reported as of quarter end, filed up to ~45 days later, not live positions.
Sort: Size Weight change
Sorted by reported value on the latest filing.
| Manager | Period | Change | Value | Weight | Prev weight | Shares | Δ shares |
|---|---|---|---|---|---|---|---|
| Duquesne Family Office LLC | Q2 2026 | ADD | $25.6M | 0.6 % | 0.6 % | 208,900 | +49,200 |
| Bridgewater Associates, LP | Q2 2026 | ADD | $1.1M | 0.0 % | 0.0 % | 9,269 | +3,993 |